Results for tag: "Hyperlipidemia Drug"

The Hyperlipidemia Drug market is a subset of the Cardiovascular Drugs market, which focuses on the treatment of high levels of lipids in the blood. Hyperlipidemia is a condition that can lead to an increased risk of heart disease, stroke, and other cardiovascular diseases. Common treatments for hyperlipidemia include statins, fibrates, and cholesterol absorption inhibitors. Statins are the most commonly prescribed drugs for hyperlipidemia, as they are effective in reducing cholesterol levels. Fibrates are used to reduce triglyceride levels, while cholesterol absorption inhibitors reduce the absorption of cholesterol from the diet. Some companies in the Hyperlipidemia Drug market include Pfizer, Merck, AstraZeneca, Sanofi, and Bristol-Myers Squibb. Show Less Read more